Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_43a72884e25aaecffebe0942132d704f |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02A50-30 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-215 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-47 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-17 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-215 |
filingDate |
2010-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2011-11-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
EP-2383286-A1 |
titleOfInvention |
Methods and compositions for treatment of retinal degenerative diseases |
abstract |
The present invention relates to an isolated nucleic acid molecule comprising i) a nucleotide sequence coding for a hyperpolarizing light-gated ion channel or pump gene from an archeon or for a light-active fragment of said gene, or the nucleotide sequence and ii) a nucleotide sequence coding for a RdCVF polypeptide for use in the treatment of a retinal degenerative disease. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10004780-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2909232-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020079464-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013124477-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014060517-A1 |
priorityDate |
2010-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |